Learned by Reading
In the ICWSM 2009 Weblog Corpus:
This causes less activation of the receptor, the neuron stops firing, and a series of brain events occur that result in withdrawal.
(Parse)
(S1 (S (S (NP (DT This))
(VP (VBZ causes)
(NP (NP (JJR less) (NN activation))
(PP (IN of)
(NP (DT the) (NN receptor)))
(, ,)
(S (NP (DT the) (NN neuron))
(VP (VBZ stops)
(NP (NN firing))))
(, ,) (CC and)
(S (NP (NP (DT a) (NN series))
(PP (IN of)
(NP (NN brain) (NNS events))))
(VP (VB occur)
(NP (DT that) (NN result))
(PP (IN in)
(NP (NN withdrawal)))))
(. .)))
In Wikipedia:
Activation of the H2 receptor results in the following physiological responses :
(Parse)
(S1 (S (NP (NP (NN Activation))
(PP (IN of)
(NP (DT the) (NNP H2) (NN receptor))))
(VP (VBZ results)
(PP (IN in)
(NP (DT the) (JJ following) (JJ physiological) (NNS responses))))
(: :)))
In Wikipedia:
Activation of the receptor is important for the innate immune response in human skin.
(Parse)
(S1 (S (NP (NP (NN Activation))
(PP (IN of)
(NP (DT the) (NN receptor))))
(VP (AUX is)
(ADJP (JJ important)
(PP (IN for)
(NP (DT the) (JJ innate) (JJ immune) (NN response))))
(PP (IN in)
(NP (JJ human) (NN skin))))
(. .)))
In Wikipedia:
It has been suggested that oxytocin release may contribute to the antiaggressive and anxiolytic properties observed upon activation of the receptor.
(Parse)
(S1 (S (NP (PRP It))
(VP (AUX has)
(VP (AUX been)
(VP (VBN suggested)
(SBAR (IN that)
(S (NP (JJ oxytocin) (NN release))
(VP (MD may)
(VP (VB contribute)
(PP (TO to)
(NP (NP (DT the)
(ADJP (JJ antiaggressive) (CC and) (JJ anxiolytic)) (NNS properties))
(VP (VBN observed)
(PP (IN upon)
(NP (NP (NN activation))
(PP (IN of)
(NP (DT the) (NN receptor)))
(. .)))
In Wikipedia:
ANP activation of the ANP catalytic receptor will stimulate its intracellular guanylyl cyclase activity to convert GTP to cGMP. cGMP will then stimulate cGMP – dependent protein kinase (PKG) which will then induce smooth muscle relaxation.
(Parse)
(S1 (S (NP (NP (CD ANP) (NN activation))
(PP (IN of)
(NP (DT the) (JJ ANP) (JJ catalytic) (NN receptor))))
(VP (MD will)
(VP (VB stimulate)
(NP (PRP$ its) (JJ intracellular) (NN guanylyl) (NN cyclase))
(S (NP (NN activity))
(VP (TO to)
(VP (VB convert)
(NP (NNS GTP))
(PP (TO to)
(NP (NN cGMP)))))
(. .))
(SBAR (S (NP (NN cGMP))
(VP (MD will) (ADVP (RB then))
(VP (VB stimulate)
(NP (NP (NN cGMP)) (: -)
(NP (JJ dependent) (NN protein)))
(NP (NP (NN kinase)) (PRN (-LRB- -LRB-)
(NP (NNP PKG)) (-RRB- -RRB-))
(SBAR (WHNP (WDT which))
(S (VP (MD will) (ADVP (RB then))
(VP (VB induce)
(NP (JJ smooth) (NN muscle) (NN relaxation))))
(. .)))
In Wikipedia:
The activation of Trk receptors by neurotrophin binding may lead to activation of signal cascades resulting in promoting survival and other functional regulation of cells.
(Parse)
(S1 (S (NP (NP (DT The) (NN activation))
(PP (IN of)
(NP (NNP Trk) (NNS receptors)))
(PP (IN by)
(NP (NN neurotrophin) (VBG binding))))
(VP (MD may)
(VP (VB lead)
(PP (TO to)
(NP (NP (NN activation))
(PP (IN of)
(NP (NP (NN signal) (NNS cascades))
(VP (VBG resulting)
(PP (IN in)
(S (VP (VBG promoting)
(NP (NP (NN survival)) (CC and)
(NP (NP (JJ other) (JJ functional) (NN regulation))
(PP (IN of)
(NP (NNS cells)))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Activation of this receptor changed vitamin D from a passive to an active form.
(Parse)
(S1 (S (NP (NP (NN Activation))
(PP (IN of)
(NP (DT this) (NN receptor))))
(VP (VBD changed)
(NP (JJ vitamin) (NNP D))
(PP (PP (IN from)
(NP (DT a) (NN passive)))
(PP (TO to)
(NP (DT an) (JJ active) (NN form)))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
The basolateral nucleus of the amygdala (BLA) receives cholinergic innervation from the basal forebrain and nicotine, via activation of neuronal nicotinic acetylcholine receptors (nAChRs), can improve performance in amygdala – based learning tasks.
(Parse)
(S1 (S (NP (NP (DT The) (JJ basolateral) (NN nucleus))
(PP (IN of)
(NP (DT the) (NN amygdala)))
(PRN (-LRB- -LRB-)
(NP (NNP BLA)) (-RRB- -RRB-)))
(VP (VBZ receives)
(NP (JJ cholinergic) (NN innervation))
(PP (IN from)
(NP (DT the) (JJ basal) (NN forebrain) (CC and) (NN nicotine)))
(, ,)
(PP (IN via)
(NP (NP (NN activation))
(PP (IN of)
(NP (NP (JJ neuronal) (JJ nicotinic) (JJ acetylcholine) (NNS receptors)) (PRN (-LRB- -LRB-) (NNS nAChRs) (-RRB- -RRB-) (, ,)
(VP (MD can)
(VP (VB improve)
(NP (NN performance))
(PP (IN in)
(NP (NN amygdala)))))
(: -))
(VP (VBN based)
(S (VP (VBG learning)
(NP (NNS tasks))))
(. .)))
In Wikipedia:
This activation of receptors by nicotine modifies the state of neurons through two main mechanisms.
(Parse)
(S1 (S (NP (NP (DT This) (NN activation))
(PP (IN of)
(NP (NP (NNS receptors))
(PP (IN by)
(NP (NN nicotine)))
(VP (VBZ modifies)
(NP (NP (DT the) (NN state))
(PP (IN of)
(NP (NNS neurons))))
(PP (IN through)
(NP (CD two) (JJ main) (NNS mechanisms))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Is an edocrine disruptor, and can cause an activation of cellular estrogen receptors (even at low levels) This is implicated in causes of a rise in breast and prostate cancer, infertility issues, a decline in amphibian populations and the reversal / feminization of birds, fish or reptiles.
(Parse)
(S1 (S (VP (VP (AUX Is)
(NP (DT an) (JJ edocrine) (NN disruptor)))
(, ,) (CC and)
(VP (MD can)
(VP (VB cause)
(NP (NP (DT an) (NN activation))
(PP (IN of)
(NP (JJ cellular) (JJ estrogen) (NNS receptors))))
(PRN (-LRB- -LRB-)
(PP (ADVP (RB even)) (IN at)
(NP (JJ low) (NNS levels)))
(-RRB- -RRB-))
(SBAR (S (NP (DT This))
(VP (AUX is)
(VP (VBN implicated)
(PP (IN in)
(NP (NP (NNS causes))
(PP (IN of)
(NP (NP (NP (DT a) (NN rise))
(PP (IN in)
(NP (NN breast) (CC and) (NN prostate) (NN cancer))))
(, ,)
(NP (NN infertility) (NNS issues)) (, ,)
(NP (NP (DT a) (NN decline))
(PP (IN in)
(NP (JJ amphibian) (NNS populations))))
(CC and)
(NP (NP (DT the) (NN reversal) (NN /) (NN feminization))
(PP (IN of)
(NP (NNS birds) (, ,) (NN fish) (CC or) (NNS reptiles)))
(. .)))
In the ICWSM 2009 Weblog Corpus:
This binding inhibits the activation of the receptor and the subsequent signal – transduction pathway, which results in reducing both the invasion of normal tissues by tumor cells and the spread of tumors to new sites.
(Parse)
(S1 (S (NP (DT This) (VBG binding))
(VP (VBZ inhibits)
(NP (NP (NP (DT the) (NN activation))
(PP (IN of)
(NP (NP (DT the) (NN receptor)) (CC and)
(NP (DT the) (JJ subsequent) (NN signal)))))
(: -)
(NP (NN transduction) (NN pathway)) (, ,)
(SBAR (WHNP (WDT which))
(S (VP (VBZ results)
(PP (IN in)
(S (VP (VBG reducing)
(NP (PDT both)
(NP (NP (DT the) (NN invasion))
(PP (IN of)
(NP (JJ normal) (NNS tissues)))
(PP (IN by)
(NP (NN tumor) (NNS cells))))
(CC and)
(NP (NP (DT the) (NN spread))
(PP (IN of)
(NP (NNS tumors)))))
(PP (TO to)
(NP (JJ new) (NNS sites)))))
(. .)))
In the British National Corpus:
One possibility is K +, which will be released from the postsynaptic cell during a tetanus to a degree that will, in part, reflect the level of activation of NMDA receptors.
(Parse)
(S1 (S (NP (CD One) (NN possibility))
(VP (AUX is)
(NP (NP (NNP K) (NNP +)) (, ,)
(SBAR (WHNP (WDT which))
(S (VP (MD will)
(VP (AUX be)
(VP (VBN released)
(PP (IN from)
(NP (DT the) (JJ postsynaptic) (NN cell)))
(PP (IN during)
(NP (NP (DT a) (NN tetanus))
(PP (TO to)
(NP (NP (DT a) (NN degree))
(SBAR (WHNP (WDT that))
(S (VP (MD will) (, ,)
(PP (IN in)
(NP (NN part)))
(, ,)
(VP (VB reflect)
(NP (NP (DT the) (NN level))
(PP (IN of)
(NP (NP (NN activation))
(PP (IN of)
(NP (NNP NMDA) (NNS receptors)))
(. .)))
In the British National Corpus:
This unsaturated fatty acid satisfies several of the requirements for a retrograde messenger: (1) it is released from cultured neurons into the extracellular medium by the activation of NMDA receptors, (2) there is an increase in its efflux and postsynaptic availability following the induction of LTP, (3) inhibitors of phospholipase A 2, an enzyme that liberates arachidonic acid from phospholipids, block the induction of LTP r134-135, and (4) the transient application of arachidonic acid to hippocampal synapses causes a slow-onset potentiation.
(Parse)
(S1 (S (NP (DT This) (JJ unsaturated) (NN fatty) (NN acid))
(VP (VBZ satisfies)
(ADJP (JJ several)
(PP (IN of)
(NP (NP (DT the) (NNS requirements))
(PP (IN for)
(NP (DT a) (NN retrograde) (NN messenger)))
(: :)
(S (S (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-))
(NP (PRP it))
(VP (AUX is)
(VP (VBN released)
(PP (IN from)
(NP (NP (JJ cultured) (NNS neurons))
(PP (IN into)
(NP (NP (DT the) (JJ extracellular) (NN medium))
(PP (IN by)
(NP (NP (DT the) (NN activation))
(PP (IN of)
(NP (NP (NNP NMDA) (NNS receptors)) (PRN (, ,) (-LRB- -LRB-)
(NP (CD 2)) (-RRB- -RRB-)))))
(ADVP (RB there))))
(VP (AUX is)
(NP (NP (DT an) (NN increase))
(PP (IN in)
(NP (NP (PRP$ its) (NN efflux)) (CC and)
(NP (NP (JJ postsynaptic) (NN availability))
(VP (VBG following)
(NP (NP (DT the) (NN induction))
(PP (IN of)
(NP (NP (NNP LTP) (, ,) (PRN (-LRB- -LRB-)
(NP (CD 3)) (-RRB- -RRB-)) (NNS inhibitors))
(PP (IN of)
(NP (NN phospholipase)))
(NP (NP (DT A) (CD 2)) (, ,)
(NP (NP (DT an) (NN enzyme))
(SBAR (WHNP (WDT that))
(S (VP (VBZ liberates)
(NP (JJ arachidonic) (NN acid))
(PP (IN from)
(NP (NNS phospholipids)))
(, ,)
(S (VP (VB block)
(NP (DT the) (NN induction))
(PP (IN of)
(NP (QP (CD LTP) (CD r134-135)))))
(, ,) (CC and)
(S (LST (-LRB- -LRB-) (LS 4) (-RRB- -RRB-))
(NP (NP (DT the) (JJ transient) (NN application))
(PP (IN of)
(NP (JJ arachidonic) (NN acid)))
(PP (TO to)
(NP (JJ hippocampal) (NNS synapses))))
(VP (VBZ causes)
(NP (DT a) (JJ slow-onset) (NN potentiation)))
(. .)))
In Wikipedia:
Activation of GABA receptors on these cells, whether they are ionotropic or metabotropic, typically results in the influx of chloride ions into that target cell.
(Parse)
(S1 (S (NP (NP (NN Activation))
(PP (IN of)
(NP (NP (NNP GABA) (NNS receptors))
(PP (IN on)
(NP (DT these) (NNS cells)))))
(, ,)
(SBAR (IN whether)
(S (NP (PRP they))
(VP (AUX are)
(ADJP (JJ ionotropic) (CC or) (JJ metabotropic)))))
(, ,)) (ADVP (RB typically))
(VP (VBZ results)
(PP (IN in)
(NP (NP (DT the) (NN influx))
(PP (IN of)
(NP (NN chloride) (NNS ions)))))
(PP (IN into)
(NP (DT that) (NN target) (NN cell))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
The data showed absence of activation of PPARgamma receptors.
(Parse)
(S1 (S (NP (DT The) (NNS data))
(VP (VBD showed)
(NP (NP (NN absence))
(PP (IN of)
(NP (NP (NN activation))
(PP (IN of)
(NP (NNP PPARgamma) (NNS receptors))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Screening of peptides encoded by other flps did not result in a significant activation of the receptor.
(Parse)
(S1 (S (NP (NP (NN Screening))
(PP (IN of)
(NP (NNS peptides)))
(VP (VBN encoded)
(PP (IN by)
(NP (JJ other) (NNS flps)))))
(VP (AUX did) (RB not)
(VP (VB result)
(PP (IN in)
(NP (NP (DT a) (JJ significant) (NN activation))
(PP (IN of)
(NP (DT the) (NN receptor))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
The reinforcing properties of muscimol depended on the activation of local GABAA receptors in the MSDB and, secondarily, on a release of DA from the VTA and consecutive activation of D1 and D2 / D3 dopaminergic receptors.
(Parse)
(S1 (S (NP (NP (DT The) (VBG reinforcing) (NNS properties))
(PP (IN of)
(NP (NN muscimol))))
(VP (VBD depended)
(PP (IN on)
(NP (NP (DT the) (NN activation))
(PP (IN of)
(NP (NP (JJ local) (NNP GABAA) (NNS receptors))
(PP (IN in)
(NP (NP (DT the) (NNP MSDB)) (CC and) (, ,) (ADVP (RB secondarily)) (, ,))))
(PP (IN on)
(NP (NP (NP (DT a) (NN release))
(PP (IN of)
(NP (NNP DA)))
(PP (IN from)
(NP (DT the) (NNP VTA))))
(CC and)
(NP (NP (JJ consecutive) (NN activation))
(PP (IN of)
(NP (NNP D1) (CC and) (NNP D2) (NNP /) (NNP D3) (JJ dopaminergic) (NNS receptors))))
(. .)))
In Wikipedia:
Activation of the receptor can cause apoptosis.
(Parse)
(S1 (S (NP (NP (NN Activation))
(PP (IN of)
(NP (DT the) (NN receptor))))
(VP (MD can)
(VP (VB cause)
(NP (NN apoptosis))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Activation of the androgen receptor is a key mechanism in the action of AAS.
(Parse)
(S1 (S (NP (NP (NN Activation))
(PP (IN of)
(NP (DT the) (JJ androgen) (NN receptor))))
(VP (AUX is)
(NP (NP (DT a) (JJ key) (NN mechanism))
(PP (IN in)
(NP (NP (DT the) (NN action))
(PP (IN of)
(NP (NNP AAS))))
(. .)))
And 120 more sentences.